Thoratec Starts HeartMate II Study As Centers Apply For New LVAD Payment
This article was originally published in The Gray Sheet
Executive Summary
Thoratec plans to complete a seven-patient, 30-day trial of the HeartMate II continuous-flow left-ventricular assist device at four U.S. centers by the end of 2003